What the panel ordered
The Board rescinded the July 5, 2022 Findings and Order, substituted new findings and orders, and returned the matter to the WCJ for further proceedings consistent with the opinion.
Applicant sought reconsideration of a July 5, 2022 Findings and Order dismissing his amended application without prejudice based on res judicata/collateral estoppel; the WCJ recommended denial of reconsideration; the Appeals Board rescinded the WCJ's decision and returned the matter for further proceedings.
This docket was decided more than once. Shown here is the latest released decision; we also hold August 30, 2021.
What was disputed, and how it came out
Each issue the panel decided, with the reasoning it gave. An outcome is what this panel did on this record — not a rule, and not a prediction.
The Board granted the petition for QME panels to issue to develop the record regarding claimed injuries in neurology and oncology.
From the decision · page 12Here, applicant requested orders directing the Medical Unit to provide QME panels in neurology and oncology, on September 10, 2020 and again on February 10, 2022. In the September 10, 2020 request, applicant explained that the request for the two QME panels was based on the recommendation of Agreed Medical Evaluator (AME) Dr. Albert Kastle, who recommended in his deposition that additional medical experts evaluate applicant's claims of lymphoma and encephalitis. (Applicant's Exh. 9, 9/10/20 Petition for Order to Medical Unit, at p. 3.) The record indicates that no action was taken on this petition. A second petition, filed February 10, 2022, reiterated the request for an order that these QME panels issue. (Joint Exh. O, 2/10/22 Petition for Order to Medical Unit.) Although this request was listed as an issue for trial at the March 29, 2022 proceeding, no findings or orders were entered as to this issue in the July 5, 2022 F&O. (3/29/22 Minutes; 7/5/22 F&O.) Thus, to date, it appears that panels in neurology and oncology have not issued.